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Edited by Stuart FergusonAbstract We have performed the recombinant expression and
puriﬁcation of the reductase domain of endothelial nitric oxide
synthase (eNOS) and used it as a bait in search for interacting
proteins present in endothelial cells. Using mass spectrometry
of the bound proteins run in a PAGE–SDS gel, we were able
to identify the ryanodine receptor (RyR) as a novel eNOS-bind-
ing partner. This interaction was conﬁrmed through immunopre-
cipitation of both RyR and eNOS from endothelial cells and
cardiac myocytes. Immunoﬂuorescence data indicated that a
subpopulation of eNOS associates with RyR in perinuclear re-
gions of the cell, where eNOS might be responsible for the
known nitrosylation of RyR.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Ryanodine receptors1. Introduction
Due to its extreme reactivity and the modulation exerted on
numerous biological processes, the synthesis of nitric oxide
(NO) within the cell is a tightly controlled process. The regula-
tion of the enzymatic activity of all three nitric oxide synthases
is exerted through transcriptional and, post-translational mod-
iﬁcations (phosphorylation, myristoylation, palmitoylation)
together with an exquisite subcellular localization. In this con-
text, the interactions of the three NOSs with cellular proteins
always determine where and when NO is to be released. In
the case of endothelial nitric oxide synthase (eNOS), at least
12 cellular proteins are known to bind and modulate its activ-
ity (see [1,2], and references therein). In addition to the well-
characterized interactions with caveolin-1 and calmodulin,Abbreviations: BAEC, bovine aortic endothelial cells; eNOS, endothe-
lial nitric oxide synthase; KLH, keyhole limpet hemocyanin; MALDI,
matrix-assisted laser desorption/ionization; MS, mass spectrometry;
NO, nitric oxide; PAGE–SDS, polyacrylamide gel electrophoresis in
the presence of sodium dodecyl sulfate; PCR, polymerase chain reac-
tion; PMSF, phenylmethyl sulfonyl ﬂuoride; RyR, ryanodine receptor
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tensin AT1 receptors, caveolin-3, dynamin-2, CAT1, porin,
protein kinase B/Akt, heat shock protein of 90 kDa, NOS
interacting protein and NOS traﬃc inducer [1,2]. However,
in all the cases where the interacting region has been mapped,
these interactions involve the N-terminal heme oxygenase do-
main of eNOS and never the C-terminal reductase domain.
Consequently, we have performed the recombinant expres-
sion and puriﬁcation of a hexa-His tagged reductase domain
of eNOS and used it as bait in order to identify novel interact-
ing proteins present in endothelial cells. We clearly identiﬁed
the ryanodine receptor (RyR) as a protein that was retained
in a complex with eNOS. This direct association might be
responsible for the known modulation of RyR exerted by
nitric oxide.2. Materials and methods
2.1. Molecular cloning, recombinant expression and puriﬁcation of the
reductase domain of eNOS
We have followed a similar procedure to the previously described
cloning and recombinant expression of the full-length wild-type eNOS
in E. coli [3]. Using the bovine eNOS as template, a NdeI site was intro-
duced at amino acid position 489 and a XbaI at the 3 0 end of the gene
using polymerase chain reaction (PCR). The PCR product was ligated
into the subcloning vector pGEMT (Invitrogen) and sequenced. We
then double digested the reductase domain cDNA from pGEMT with
NdeI plus XbaI and it was ligated into the corresponding site of the
pCWori vector that possessed a hexa-His tag in the polylinker. This
plasmid was used to routinely transform BL21 competent cells
(Novagen). The recombinant expression of the reductase domain of
eNOS was performed using 6 L of 2· YT medium at 30 C. The
bacteria were lyzed and the protein was puriﬁed using two aﬃnity
columns (the Ni-NTA resin and a 2 0,5 0-ADP-Sepharose) as previously
described [3,4].
2.2. Interaction between the reductase domain of eNOS and endothelial
cells
A minimum of ﬁfteen 10 cm circular plates of fresh bovine aortic
endothelial cells (BAEC) grown in DMEM supplemented with 10% fe-
tal calf serum were scraped and resuspended in PBS. The cells were
centrifuged at 10000 · g at 4 C and the pellet was homogenized in
100 mM Tris buﬀer, pH 7.5, in the presence of 10 lg/mL pepstatin,
10 lg/mL aprotinin, 10 lg/mL leupeptin, and 2 lM phenylmethyl
sulfonyl ﬂuoride (PMSF) as protease inhibitors (buﬀer A) in a total
volume of 10 mL. The cellular suspension was then passed several
times through a syringe (0.5 · 16 mm) on ice. Unbroken cells and
cellular debris were eliminated by a 10-min centrifugation at 5000ation of European Biochemical Societies.
Fig. 1. Recombinant expression and puriﬁcation of the reductase
domain of eNOS and interaction with an endothelial cells extract. The
C-terminal reductase domain of eNOS was recombinantly expressed,
and puriﬁed using two aﬃnity resins. The absorbance spectrum of the
pure protein in the visible region together with a coomassie blue-
stained PAGE–SDS gel (inset) are shown in (A). The puriﬁed protein
was incubated with the clariﬁed cell extract, bound to the Ni-NTA
resin, eluted and analyzed by PAGE–SDS and coomassie blue staining
(B). Twelve gel stripes were excised with a clean scalpel and subjected
to MS analysis. The positions where calmodulin and RyR appear are
shown by arrows.
3160 M. Martı´nez-Moreno et al. / FEBS Letters 579 (2005) 3159–3163rpm in a table-top microcentrifuge at 4 C. This sample was loaded
onto a Ni-NTA column that contained approximately 5 mL of aﬃnity
resin and the ﬂow-through was collected. In this step, cellular proteins
that interacted non-speciﬁcally with the Ni-NTA column were re-
moved. This procedure was repeated twice in order to eliminate any
trace of proteins that might bind to the Ni-NTA resin non-speciﬁcally
following our published protocol [5]. After clariﬁcation of the total cell
extract, 1 mg of hexa-His tagged pure recombinant reductase domain
was added to the sample and allowed to interact with the cellular pro-
teins for 15 min on ice. Afterwards, the mixture was loaded onto a new
Ni-NTA resin pre-equilibrated in buﬀer A. The column was subse-
quently washed with 200 mL of 20 mM imidazole in buﬀer A and
the complexes of reductase bound speciﬁcally to endothelial cells pro-
teins were eluted with 200 mM imidazole. The absorbance of each col-
lected fraction of eluate was measured at 280 nm. The fractions that
contained protein were collected and the pool was extensively dialyzed
(3 kDa cut-oﬀ) against 50 mM (NH4)HCO3, pH 8.0, in the presence of
2 lM PMSF. After the dialysis, the sample was lyophilized and stored
at 80 C.
2.3. SDS–PAGE and mass spectrometry (MS) analysis
The lyophilized sample was dissolved in SDS–PAGE loading buﬀer
in the presence of 1% v/v b-mercaptoethanol, boiled for 5 min and re-
solved on a 15% acrylamide gel. Staining of the gel was performed with
coomassie brilliant blue for 30 min. The coomassie-stained bands were
excised with a sharp cutter and transferred to a clean Eppendorﬀ tube.
The proteomics analysis was performed using a Bruker Reﬂexe IV
matrix-assisted laser desorption/ionization (MALDI)-TOF mass spec-
trometer (Bruker-Franzen Analytic, Bremen, Germany) equipped with
the SCOUTe source in positive ion reﬂector mode using delayed
extraction as previously described [5].
2.4. Development of a rabbit polyclonal serum against the RyR
We synthesized two peptides corresponding to the RyR and coupled
them to keyhole limpet hemocyanin (KLH). The sequences that we
chose were: EDEIQFLRTEDEWLQ (N-terminal end of all RyR1,
RyR2 and RyR3) and the internal peptide KKAVWHKLLSQRKR.
2.5. Immunoprecipitation, immunodetection and immunoﬂuorescence of
ﬁxed cells
Cell culture and all the cellular biology experiments were performed
following our published protocols [6,7]. In each experiment we used
two 10 cm circular plates of BAEC grown on DMEM in the presence
of 10% serum. A minimum of two independent experiments were per-
formed every time. The anti-eNOS rabbit polyclonal antibody was
purchased from Sigma (cat. N3893) and the anti-caveolin-1 rabbit
polyclonal antibody was purchased from BD Biosciences (cat.
610060). The anti-RyR rabbit polyclonal serum used in all the experi-
ments was elicited in our laboratory and recognized the N-terminal
end of RyR.
2.6. Molecular cloning and expression of the full-length eNOS-GFP
construct
The full-length eNOS gene was ampliﬁed by PCR inserting an
EcoRI site and a BssHII at the 5 0 and 3 0 end, respectively, subcloned
into pGEMT (Invitrogen), sequenced, double digested with EcoRI plus
BssHII and ligated into the corresponding sites of pCDNA3-GFP
[6,7].3. Results
3.1. Recombinant expression of the reductase domain of eNOS
The puriﬁcation of the reductase domain of eNOS expressed
in E. coli rendered an homogeneous protein band of 80.6 kDa
according to PAGE–SDS, and displayed an absorption spec-
trum in the visible region characteristic of a ﬂavoprotein
(Fig. 1A). As expected, the absorbance spectrum showed two
maxima, centered at 385 and 455 nm, characteristic of proteins
with FAD and FMN. We were able to obtain approximately 2
mg of pure protein per liter of cell culture.3.2. Identiﬁcation of reductase-interacting proteins by MS
In order to rule out non-speciﬁc interactions of the reductase
domain of eNOS with proteins obtained from endothelial tis-
sues, we ﬁrst clariﬁed the cell lysate loading it twice in the
Ni-NTA agarose resin. The ﬂow-through was then allowed
to interact with the hex-His tagged reductase domain of eNOS
and it was loaded again in the aﬃnity column. After elution
with 200 mM imidazole, dialysis and liophilization, the sample
was run in a one-dimensional SDS gel and analyzed by MAL-
DI-TOF (Fig. 1B). When we loaded over 30 lg of total protein
in one lane, many bands could be identiﬁed after coomassie
blue staining. We cut 10 bands ranging from 10 to over 500
kDa and we tried to identify them by MS. However, in most
of the cases, we retrieved fragments of the eNOS reductase
(probably resulting from proteases present in the cell lysate).
Nevertheless, two proteins could be identiﬁed unambiguously,
Fig. 2. Co-immunoprecipitation of eNOS and RyR in both BAEC and
H9C2 cells. The protein mixture eluted from the Ni-NTA resin was
immunoprecipitated and immunodetected with anti-RyR antibodies
(A) showing the expected band at 565 kDa. A cell lysate of BAEC
was immunoprecipitated with both anti-eNOS and anti-RyR antibod-
ies (B) and analyzed by Western blot using anti eNOS (left panel) and
anti-RyR antibodies (right panel). H9C2 cardiac myocytes were also
immunoprecipitated using both anti-eNOS and anti-RyR antibodies
and the samples were subsequently analyzed by Western blot using
anti-RyR antibodies (C).
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calmodulin-binding site is present in our recombinant protein
(just after the hexa-His tag), this result was somehow expected.
Interestingly, we could also identify the ryanodine receptor as
an eNOS-interacting protein that was present in the large
molecular mass bands that were present in the gel. In total,
we retrieved 27 peptides covering the protein sequence of
RyR (a protein with a theoretical molecular mass of 565
kDa), six of which were oxidized in Met residues. Conse-
quently, we were able to identify this calcium channel as a no-
vel protein that bound to the C-terminal domain of eNOS.
3.3. Co-immunoprecipitation
Although endothelial cells express Ryanodine receptors [8–
10], they do so at low levels. Since we could not detect Western
blot bands using the commercially available anti-RyR antibod-
ies, we elicited our own sera using synthetic peptides. We ob-
tained an excellent anti serum immunizing the rabbits with a
KLH-coupled N-terminus peptide that displays identical se-
quence among all RyR1, RyR2 and RyR3. When, using this
serum, we immunoprecipitated the RyR from the BAEC pro-
tein extract that interacted with the reductase domain of eNOS
we could immunodetect a very signiﬁcant band of RyRs at a
molecular mass of 565 kDa (Fig. 2A). Next, we performed
the immunoprecipitation of both eNOS and RyR in the endo-
thelial cell lysate and immunodetected for both eNOS and
RyR (Fig. 2B). The eNOS antibody could immunoprecipitate
a signiﬁcant amount of eNOS protein, as detected by Western
blot against eNOS itself, whereas the RyR antibody could
immunoprecipitate a much smaller amount of total eNOS pro-
tein (Fig. 2B, left panel). The symmetrical experiment, where
we determined by Western blot against RyR the amount
immunoprecipitated with both the RyR and the eNOS anti-
body rendered a similar result (Fig. 2B, right panel), hence
conﬁrming the interaction between eNOS and RyR. Hence,
although both eNOS and RyR can be signiﬁcantly immuno-
precipitated, the amount that becomes co-immunoprecipitated
is limited. This result is indicative that only a subset of the total
eNOS protein is associated with RyR (see below). It must be
noted that a pre-immune serum was unable to give any positive
band in this co-immunoprecipitation experiments (data not
shown). Interestingly, the large amount of RyR that remains
interacting with the reductase domain of eNOS bound to the
aﬃnity resin (Fig. 2A) might result not only from the much lar-
ger amount of cell lysate used in this experiment but also from
a more stable association of RyR with the reductase domain of
eNOS than with the full-length protein.
In the cardiac myocytes cell line H9C2 where eNOS expres-
sion is very limited but RyR expression is abundant, co-immu-
noprecipitation of RyR using anti-eNOS antibodies could also
be observed (Fig. 2C). Consequently, this eNOS-RyR might be
present in more cell types in addition to endothelial cells.
3.4. Immunoﬂuorescence
In order to inspect the subcellular distribution of eNOS in
endothelial cells we performed laser confocal microscopy of
both BAEC and H9C2 cells (Fig. 3). As expected, endothelial
cells display perinuclear accumulation as well as cytosolic
labeling of eNOS. The staining of caveolin-1, a protein which
is known to partially associate to eNOS, is more limited to the
plasma membrane regions and to cell–cell contacts. On the
other hand, the RyR immunoﬂuorescence accumulated in
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cytoplasm. When the eNOS-RyR signals were overlapped,
co-immunolocalization could be observed in these perinuclear
regions, very likely the endoplasmic reticulum (shown with ar-
rows). Quantiﬁcation of this overlap allowed us to determine
that 28% of the RyR signal overlapped with the eNOS signal
whereas only 3% of the eNOS immunoﬂuorescence overlapped
with the RyR distribution. On the other hand, expression of
RyR in H9C2 cardiac myocytes is more abundant (Fig. 3, bot-
tom panels) although a very limited overlap with the caveolin-
1 staining could be observed.
With the intention of determining the subcellular distribu-
tion of eNOS and RyR in a cell line that expressed larger
amounts of both proteins we created an eNOS-GFP construct
and used it to transfect H9C2 myocytes (Fig. 4). A clear over-
lap between the eNOS and RyR immunoﬂuorescence could be
observed in ﬁber-like structures that extend along the cyto-
plasm. Whereas RyR staining is more limited to perinuclear re-Fig. 4. Laser confocal microscopy immunoﬂuorescence of the H9C2 cell line
anti-RyR antibodies. Live H9C2 cells grown on coated glass coverslips tran
paraformaldehyde plus cold methanol. The subcellular distribution of both th
staining. The RyR ﬂuorescence was visualized at an excitation wavelength
construct was obtained after excitation at 488 nm and is shown in green. T
Hoechst and excitation at 405 nm.
Fig. 3. Laser confocal microscopy immunoﬂuorescence of both BAEC and H
ﬁxed with 3.7% paraformaldehyde plus cold methanol. The subcellular distr
microscopy in a triple staining. The RyR ﬂuorescence was visualized at an ex
and caveolin-1 ﬂuorescence was obtained after excitation at 488 nm and is sh
staining with Hoechst and excitation at 405 nm.gions, eNOS excludes from the cell nucleus and distributes
along the entire cytosol. This data is agreement with our pre-
vious observation that only a partial amount of the total eNOS
protein directly associates with RyR. We could quantify that
58% of the RyR ﬂuorescence overlapped with eNOS whereas
63% of the eNOS signal overlapped with RyR.4. Discussion
The large, homotetrameric skeletal muscle Ca2+ release
channel/RyR1 contains several classes of regulatory thiols.
These classes are distinguished by reactivity or responsiveness
to O2 tension (pO2) [11,12], redox active molecules such as glu-
tathione [13] and nitric oxide (ÆNO) [11], transmembrane gluta-
thione redox potential [14], and allosteric eﬀector molecules
(Ca2+,Mg2+) [15]. It has recently been shown that cysteineof cardiac myotubes transfected with eNOS-GFP and incubated with
sfected with the wild-type eNOS-GFP construct were ﬁxed with 3.7%
e eNOS and RyR was analyzed by laser confocal microscopy in a triple
of 543 nm and is shown in red, whereas the GFP ﬂuorescence of the
he position of the cell nuclei (blue) was obtained after staining with
9C2 cardiac myotubes. Live cells grown on coated glass coverslips were
ibution of eNOS, caveolin-1 and RyR was analyzed by laser confocal
citation wavelength of 543 nm and is shown in red, whereas the eNOS
own in green. The position of the cell nuclei (blue) was obtained after
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RyR1 [11], confers responsiveness to NO. In contrast, the iden-
tities of the remaining regulatory thiols are not known. NO
forms a covalent bond with the thiol group of Cys-3635 (i.e.,
S-nitrosylation) in vivo and thereby reverses the inhibitory ef-
fect of CaM on the channel [11]. Full-length RyR1 channels
with an alanine residue substituted for Cys-3635 are not S-nit-
rosylated by physiological concentrations of NO, and channel
activity is unaﬀected by NO. S-nitrosylation of Cys-3635 only
occurs at low O2 tension (pO2  10 mmHg, comparable with
that found in skeletal muscle in vivo) [11].
It has been known for some time now that NO stimulated
the release of Ca2+ from the sarcoplasmic reticulum leading
to variable eﬀects on myocardial contractility. When total
heart extracts were immunoprecipitated with anti-RyR anti-
bodies, certain nNOS immunoreactivity could be observed
[16]. However, the interaction between eNOS and RyR has
been not reported so far. Thus, our data indicate that this
interaction between RyR and nitric oxide synthases occur
through the C-terminal reductase domain of the NOSs. In
addition, we describe that not only nNOS, but eNOS also
can be responsible for the RyR channel activity, a process
known to be regulated by cysteine nitrosylation.
In addition, we observed that only a small amount of the to-
tal eNOS protein present in endothelial cells appears in associ-
ation with the ryanodine channel, and this subpopulation is
not associated with caveolin-1. It is tempting to speculate that
certain post-translational modiﬁcations of eNOS such as phos-
phorylation or the recently described S-nitrosylation [17] might
be responsible for the association of eNOS with RyR. The
proximity of both proteins very likely facilitates the well-char-
acterized nitrosylation of RyR responsible for the ﬁne tuning
of its enzymatic activity.Acknowledgments: We thank Raquel Nieto for excellent technical
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